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ORIGINAL ARTICLE
von Willebrand factor stimulates thrombin-induced exposure
of procoagulant phospholipids on the surface of
fibrin-adherent platelets
J . J . B R I E D E´ ,  S . J . H . W I E LD E R S ,  J . W . M . H EE M S K E R K , D . B A R U C H , yH . C . H E M K E R  and T . L I N D H O U T 
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; and yINSERM
U143, Le Kremlin-Biceˆtre, France
Summary. Studies from our laboratory have demonstrated that
von Willebrand factor (VWF) stimulates thrombin generation in
platelet-rich plasma. The precise role of VWF and fibrin in this
reaction, however, remained to be clarified. In the present study
we utilized thrombin-free planar fibrin layers and washed
platelets to examine the relationship between platelet–fibrin
interaction and exposure of coagulation-stimulating phospha-
tidylserine (PS) under conditions of low and high shear stress.
Our study confirms that platelet adhesion to fibrin at a shear rate
of 1000 s1 requires fibrin-bound VWF. The cytosolic calcium
concentration ([Ca2þ]i) of stationary platelets was not elevated
and PS exposing platelets were virtually absent (2 2%). How-
ever, thrombin activation resulted in a marked increase in the
number of PS exposing platelets (up to 85 14%) along with a
transient elevation in [Ca2þ]i from 0.05mmol L
1 up to 1.1
0.2 mmol L1. Platelet adhesion to fibrin at a shear rate of 50 s1
is mediated by thrombin but not by fibrin-bound VWF. The
[Ca2þ]i of these thrombin-activated platelets was elevated
(0.2 0.1mmol L1), but only a minority of the platelets
(11 8%) exposed PS. The essential role of VWF in this throm-
bin-induced procoagulant response became apparent from low
shear rate perfusion studies over fibrin that was incubated with
VWF and botrocetin. After treatment with thrombin, the ma-
jority of the adherent platelets (57 23%) exposed PS and had
peak values of [Ca2þ]i of about 0.6 mmol L
1. Taken together,
these results demonstrate that thrombin-induced exposure of PS
and high calcium response on fibrin-adherent platelets depends
on shear- or botrocetin-induced VWF–platelet interaction.
Keywords: fibrin, platelet procoagulant activity, von Wille-
brand factor.
Thrombus formation at an injured vessel wall involves platelet
adhesion, platelet activation and fibrin formation. Previous
studies have provided evidence that fibrin, besides physically
entrapping platelets [1], may also be involved in signal path-
ways that result in the exposure of anionic phospholipids (PS) at
the plasma membrane of platelets [2,3]. The presence of PS in
the outer leaflet of the platelet plasma membrane is of physio-
logical importance because of its critical role in maintaining
thrombin generation at the surface of a developing thrombus [4].
Platelets adhere to fibrin by molecular mechanisms that vary
with the surface shear rate [5,6]. At low shear rates, platelet
adhesion is mediated by integrin aIIbb3 whereas at high shear
rates an interaction between platelet glycoprotein (GP) Ib and
fibrin-bound von Willebrand factor (VWF) tethers the platelets
as a prerequisite for an irreversible, integrin aIIbb3-mediated,
adhesion to fibrin [7–10].
Recently, conflicting reports appeared on the role for GPIb in
the development of procoagulant platelets. Studies in platelet-
rich plasma revealed that VWF supports thrombin generation
by two mechanisms: one that involves integrin aIIbb3 but not
fibrin and another one that depends on both fibrin and GPIb [3].
Other investigators studied the thrombin-dependent expression
of procoagulant activity in suspensions of gel-filtered platelets
and found that the GPIb binding site for thrombin, but not that
for VWF, has a key role in the exposure of procoagulant phos-
pholipids on the platelet surface, implying that VWF does not
function in this response [11]. Earlier studies, however, indi-
cated that PAR1 is the primary mediator of thrombin-stimulated
platelet procoagulant activity, implicating that GPIb does not
play a major role [12]. Thus, it remains to be clarified what role
GPIb and the interaction with its physiological ligand VWF
plays in the exposure of procoagulant PS.
In this study, we examined the stimulatory effect of fibrin-
bound VWF on the procoagulant response of fibrin-adherent
platelets under flow conditions, utilizing a plasma free system to
avoid any contribution of in situ generated thrombin. The
procoagulant response was probed by the binding of annexin
V in addition to changes in the cytosolic calcium concentration
of adherent platelets. The data confirms that stable adhesion to
fibrin requires VWF at high but not at low shear rate. This
interaction does not result in increased cytosolic calcium levels,
or in the exposure of PS. However, GPIb-VWF-mediated
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adhesion of platelets to fibrin appears to be a prerequisite for
thrombin to induce PS exposure in association with transiently
increased cytosolic calcium levels.
Materials and methods
Materials
Unfractionated heparin and bovine serum albumin (Sigma, St.
Louis, USA); chromogenic substrate for thrombin, S2238
(Chromogenix, Mo¨lndal, Sweden); D-Phe-Pro-Arg chloro-
methylketone (Calbiochem, San Diego, USA); 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-gly-
cero-3-phosphoserine (DOPS) (Avanti Polar Lipids, Alabaster,
AL, USA); calcein acetoxymethyl ester and fura-2 acetoxy
methyl ester (Molecular Probes, Leiden, the Netherlands)
and botrocetin (Kordia, Leiden, the Netherlands) were pur-
chased from commercial sources as indicated.
Proteins and antibodies
Recombinant human tissue factor was a kind gift of Dr Y.
Nemerson (Mount Sinai School of Medicine, New York, NY,
USA) and was relipidated as described before [13]. Human a-
thrombin was prepared as previously described [14]. An affinity
purified polyclonal rabbit antihuman VWF antibody was
obtained from the Central Laboratory of the Red Cross (Amster-
dam, the Netherlands). Monovalent Fab fragments of a mono-
clonal antibody directed against GP Ib (6B4 Fab) described
previously [15] were a kind gift of Dr H. Deckmyn (Laboratory
for Thrombosis Research, Kortrijk, Belgium). Fluorescein iso-
thiocyanate (FITC) labeled swine antirabbit IgG was from Dako
A/S (Glostrup, Denmark). Purified VWF and a monoclonal
antibody (MoAb 9) directed against the platelet aIIbb3 binding
site on VWF were described before [16]. Oregon Green 488-
labeled annexin V came from Nexins Research (Hoeven, the
Netherlands). The source of the platelet aIIbb3 receptor blocker
abciximab was as described [17]. The specific protease-acti-
vated receptor 1 (PAR1) ligand SFLLRN was obtained from
Bachem (Bubendorf, Switzerland).
Platelets
Suspensions of washed platelets were prepared as described
previously [18]. The supernatant of the final wash-step con-
tained less than 3 ng mL1 VWF. Where indicated, platelet-rich
plasma was incubated with 2.5 mmol L1 calcein acetoxymethyl
ester or 3mmol L1 fura-2 acetoxymethyl ester in the presence
of 0.1 U mL1 apyrase during 45 min at 37 8C. The platelets
were then spun down and washed twice with Hepes buffer
pH 6.6 (in mmol L1: 10 Hepes, 136 NaCl, 5 glucose, 2.7 KCl,
2 MgCl2, and 1 mg mL
1 bovine serum albumin) containing
apyrase (0.1 U mL1). Finally, the platelets were resuspended in
Hepes buffer adjusted to pH 7.4. Platelets were counted (Coul-
ter, Miami, FL, USA) and the suspensions were adjusted to
3.0 108 platelets mL1.
Preparation of planar fibrin layers
Fibrin layer was prepared as originally described by Remijn
et al. [19]. A parallel plate flow chamber was filled with
0.3 nmol L1 tissue factor embedded in 30 mmol L1 DOPS
(25 mol%)/DOPC (75 mol%) vesicles and incubated for 20 min.
Non-bound vesicles were removed by flushing the chamber
withTris-buffer (50 mmol L1 Tris,175 mmol L1 NaCl,pH 7.9).
Subsequently, the flow chamber was perfused (shear rate of
20 s1) with plasma that was diluted 5-fold with Tris-buffer
containing 1 U mL1 heparin and 3 mmol L1 CaCl2. After
20 min, when a network of fibrin strands was formed, the flow
chamber was flushed with Tris-buffer to remove plasma pro-
teins. Immuno-staining with primary polyclonal rabbit antihu-
man VWF antibody (10 mg/mL) during 60 min and a secondary
FITC-labeled swine antirabbit antibody (1 : 50 dilution) during
60 min revealed the presence of VWF. The fibrin layer was then
incubated for 1 h with 50 mmol L1 D-Phe-Pro-Arg chloro-
methylketone (PPACK) and with purified plasma-derived
human VWF (10mg mL1). Finally, the flow chamber was
rinsed with Hepes buffer during 10 min at a shear rate of
1000 s1. Immuno-staining for VWF as described resulted in
twofold increase in fluorescence intensity.
Platelet flow studies
The flow chamber used in this study was as described previously
[20]. Perfusion experiments with washed platelets (3.0 108
platelets mL1) in Hepes buffer containing 3 mmol L1 CaCl2
were performed at 100mL min1 in flow chambers with a slit
depth of 200mm (shear rate 50 s1) and at 125 mL min1 in flow
chambers with a slit depth of 50 mm (shear rate 1000 s1). All
procedures were performed at ambient temperature (21–22 8C).
Perfusion with thrombin-activated platelets
The inlet of the flow chamber was connected to two syringes;
one containing the platelet suspension (3.8 108 platelets -
mL1 in Hepes buffer containing 3 mmol L1 CaCl2) and the
other containing 0.5mmol L1 thrombin in Hepes buffer. The
pump-driven syringes were set at flow rates of 80 and
20mL min1, respectively, resulting in the perfusion of platelets
that were activated with 100 nmol L1 thrombin, just before
they entered the flow chamber.
Phase contrast and fluorescence microscopy
Phase contrast and fluorescent real-time images were recorded
as described before [18]. Briefly, the flow chamber was placed
on the stage of an inverted microscope (Diaphot 200, Nikon,
Tokyo, Japan). Phase contrast and fluorescence images are
recorded via a 40 quartz oil-immersion objective coupled
to a high-resolution and a low-light level intensified, charge-
coupled device camera, respectively. Oregon Green 488, calcein
and FITC fluorescence were observed with a 485-nm excitation
filter (bandpass of 40 nm), a 505-nm dichroic long-pass filter,
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and a 530-nm emission filter (bandpass of 30 nm). Four fluor-
escence images were taken every 10 s, digitized and averaged
after subtraction of background images, and the resulting
images were stored. Image analysis was performed off-line
using Quanticell 700/900 software (Visitech, Sunderland, UK).
Fura-2 fluorescence, as a probe for intracellular calcium con-
centration, was measured with alternating 340 nm and 380 nm
excitation filters (bandpass 15 nm), a 400-nm dichroic mirror
and a 510-nm emission filter (bandpass 40 nm). Four fluores-
cence images were taken every 3 s, averaged, background
subtracted and ratio images were calculated. Calibration of
fluorescence ratio to molar concentrations of intracellular cal-
cium was according to Grynkiewicz et al. [21].
Platelet adhesion is expressed as the percentage of total area
covered with fluorescent (calcein-loaded) stationary platelets,
and was calculated from at least five different microscopic fields
in three independent experiments. PS exposure is expressed as
the percentage of total area covered with platelets that bind
Oregon Green-labeled annexin V, and was calculated from at
least five different microscopic fields in three independent
experiments.
Statistics
To determine the significance of differences, P-values were
obtained with a non-parametric test for two independent vari-
ables (Mann–Whitney test).
Results and discussion
Shear-induced adhesion of platelets to fibrin and exposure
of anionic phospholipids
A thin fibrin layer was formed under flow from tissue factor-
driven coagulating human plasma at the glass coverslip surface
mounted in a parallel plate flow chamber as described in
Materials and methods. Scanning electron microscopy showed
an homogeneous coverage of the coverslip area with fibrin
strands varying in thickness from 0.1 to 0.3 mm and aligned in
the direction of the flow. No binding of Oregon Green-labeled
annexin V to the phospholipids layer underneath the fibrin layer
could be detected, suggesting a complete coverage of the glass
surface with fibrin. In all perfusion experiments fibrin layers
were used that were incubated with PPACK and VWF to
inactivate fibrin-bound thrombin and to saturate the fibrin with
VWF, respectively.
Perfusion of washed platelets at a wall shear rate of 1000 s1
over the VWF-fibrin layer resulted in a rapid surface coverage
with stationary (irreversibly bound) platelets (Fig. 1). After
10 min perfusion, the surface coverage was 75 7% (mean
 SD; n ¼ 15). This is slightly less than in similar perfusion
experiments with PPACK anticoagulated whole blood (data not
shown). Adhesion of stationary platelets appeared to depend on
the interactions between VWF and the platelet receptors GPIb
and integrin aIIbb3 for the following reasons: less than 1% of the
surface was covered after 10 min perfusion with stationary
platelets when the fibrin layer was pretreated with [1] a poly-
clonal antihuman VWF antibody (10mg mL1) or [2] a blocking
antibody (20mg mL1) against the integrin aIIbb3 binding site
on VWF (MoAb 9). Moreover, essentially no platelets adhered
when the platelets were incubated prior to perfusion with [1]
Fab fragments of MoAb 6B4 (10mg mL1) directed against the
VWF binding site on GP Ib or [2] abciximab (20mg mL1) an
integrin aIIbb3 antagonist. Taken together, these findings are
compatible with the notion that VWF must sequentially engage
both GPIba and aIIbb3 to achieve surface coverage with sta-
tionary platelets [22–24]. It has been proposed that the inter-
action between immobilized VWF and GPIba, generates an
intracellular second messenger that signals the conversion of
aIIbb3 from a low affinity to a high affinity receptor for
immobilized VWF [25,26].
Analysis of the changes in [Ca2þ]i of the stationary platelets
revealed that virtually all platelets exhibited low, non-oscillat-
ing [Ca2þ]i of around 50 nmol L
1. However, the platelets
might have exhibited transient increase in [Ca2þ]i immediately
after platelet interaction with fibrin-bound VWF, as have been
described by Nesbitt et al. [26] for interaction between im-
mobilized VWF and platelets. Accordingly, under these experi-
mental conditions, platelet binding via activated integrin aIIbb3
is not associated with at least a persistent rise in [Ca2þ]i. Similar
observations have earlier been made with platelets adhering to
fibrinogen [18] or monomeric fibrin [27]. The observation that
only 2 2% (mean  SD; n ¼ 20) of the adherent platelets
bound annexin V is in accordance with the notion that, regard-
less of the agonist, a high elevation in [Ca2þ]i (mmol L
1 range)
persisting during a certain time (minute range) is required for
evoking membrane PS exposure [18,28].
When a thrombin solution (100 nmol L1) was passed over
fibrin-adherent platelets, [Ca2þ]i transiently increased from
50 nmol L1 to a peak values of 1.1 0.2mmol L1 (mean 
SD, n ¼ 5) (Fig. 2a,b). The rapid increase in [Ca2þ]i was
accompanied with a slow increase in the number of platelets
Fig. 1. VWF-mediated platelet adhesion on fibrin. Calcein-loaded washed
platelets (3.0 108 cells mL1) resuspended in Hepes buffer pH 7.4 (in
mmol L1: 10 Hepes, 136 NaCl, 5 glucose, 2.7 KCl, 2 MgCl2, 3 CaCl2, and
1 mg mL1 bovine serum albumin) were perfused at a wall shear rate of
1000 s1over a fibrin layer that was incubated with human VWF
(10mg mL1) and PPACK (50mmol L1). Fluorescence images were
captured at different time intervals and off-line analyzed for surface
coverage. Symbols indicate: (*), control and (&), VWF-fibrin incubated
for 1 h with polyclonal antihuman VWF antibody (10mg mL1) prior to
perfusion with platelet suspension.
# 2003 International Society on Thrombosis and Haemostasis
VWF and platelet procoagulant response 561
that bound annexin V (Fig. 2c). It could be argued that transport
limitations are causing the relatively slow binding of annexin V.
Control experiments, however, showed that fibrin-adherent
platelets that were pretreated with a calcium ionophore
(5 mmol L1 ionomycin in the presence of 3 mmol L1 CaCl2)
rapidly bound annexin V when perfused under the same con-
ditions (data not shown).
Off-line analysis of the fluorescence images of randomly
chosen microscopic fields, taken 10 min after the influx of
thrombin and OG-labeled annexin V, revealed that 85 14%
(mean SD; n¼ 30) of the surface was covered with annexin V
binding platelets (Fig. 2d). By varying the thrombin concentra-
tion it appeared that 5 nmol L1 of thrombin was sufficient to
induce within 10 min the appearance of annexin V binding sites
on 50% of the adherent platelets (data not shown). This finding
sharply contrasts from the situation where thrombin is added
to platelets on fibrin(ogen) in the absence of flow and VWF.
Thrombin causes under these conditions a repetitive spiking
instead of a continuous elevation in [Ca2þ]i [29] that is not
followed by significant exposure of annexin V binding sites
[30].
To explore whether the thrombin receptors PAR1 and/or GPIb
are involved in the thrombin-induced responses of fibrin-
adherent platelets, experiments were performed in which fi-
brin-adherent platelets were incubated with the PAR1 ligand
SFLLRN (150mmol L1). Like thrombin, SFLLRN caused a
rapid and transient increase in [Ca2þ]i with a peak value of
about 0.25 mmol L1. This response was lower than the response
seen with thrombin. In contrast to the observation with throm-
bin, no increase in the number of annexin V binding platelets
was observed. That is, surface coverage with annexin V binding
platelets prior to and after treatment with SFLLRN was 2 1%
(mean  SD, n ¼ 5) and 2 2% (mean  SD, n ¼ 5), res-
pectively. It is apparent that in this flow system PAR1-signaling
alone is unable to translocate sufficient PS from the inner leaflet
to the outer leaflet of the platelet plasma membrane to bind
annexin V. This could support the previous observation that in
thrombin-induced platelet activation a cooperative role of PAR1
and GPIb is involved [31]. When the SFLLRN-treated platelets
were subsequently exposed to thrombin (100 nmol L1), a slight
increase (10%) in surface coverage with annexin V binding
platelets was found. This finding is compatible with the notion
Fig. 2. Thrombin-induced calcium response and exposure of anionic phospholipids. Fura-2 loaded platelets (3.0 108 cells mL1) resuspended in Hepes
buffer (see Fig. 1) were perfused at a wall shear rate of 1000 s1 over a fibrin layer. After 10 min, nonadherent platelets were removed by a perfusion
with Hepes buffer. The fibrin layer with adherent platelets was then perfused with 100 nmol L1 thrombin in Hepes buffer, and fura-2 fluorescence
ratio images were captured every 10 s. (a) Changes in [Ca2þ]i of 5 single platelets were averaged and plotted against the perfusion time. (b) Average [Ca
2þ]i of
fibrin-adherent platelets before perfusion with thrombin (control) and average peak values of [Ca2þ]i during perfusion with thrombin (þ thrombin)
were calculated from the data used to construct Fig. 2(a). (c) In a separate experiment fibrin-adherent platelets were perfused with Hepes buffer containing
thrombin (100 nmol L1) and OG-labeled annexin V (1mg/mL). Fluorescence images were captured at regular time intervals. Typical fluorescence
images taken 2 and 10 min after the start of the thrombin/annexin V perfusion are shown. (d) Percentage surface coverage with annexin V binding platelets
prior to thrombin (Control) and 10 min after the start with the thrombin/annexin V solution (þ thrombin).
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that SFLLRN desensitizes the thrombin-induced procoagulant
response of platelets [11].
Taken together, these results confirm that under conditions of
high shear stress, attachment of stationary platelets on fibrin
requires GPIb–VWF interaction to initiate a firm interaction
between integrin aIIbb3 and VWF or fibrin. These GPIb- and
integrin aIIbb3–mediated interactions do not result in a sub-
stantial increase in [Ca2þ]i, nor in exposure of PS in the outer
leaflet of the plasma membrane. Furthermore, under these shear
conditions, additional activation by thrombin is required to
increase the cytosolic calcium concentration to levels that
are sufficiently high to trigger PS exposure. The PAR1 agonist,
SFLLRN, when compared with thrombin, fails to induce PS
exposure under the present flow conditions.
Platelet adhesion at low shear rate and exposure of
anionic phospholipids
To find support for the notion that the shear dependent VWF–
platelet interaction, contributes to the thrombin-induced platelet
procoagulant response, similar perfusion experiments were
performed under conditions of low shear stress. In agreement
with earlier published data [32], nonactivated platelets do not
adhere on fibrin. After 10 min perfusion at a shear rate of 50 s1,
the area coverage with stationary platelets was less than 1%.
In contrast, the number of stationary platelets greatly increased
in time when the platelets were activated with thrombin
(100 nmol L1) just before they entered the flow chamber
(Fig. 3a). After 10 min perfusion, 12 7% (mean  SD; n ¼
15) of the total area was covered with adherent platelets
(Fig. 3b). In comparison with high shear condition, the rate
at which thrombin-activated platelets adhered to fibrin at low
shear stress was much slower. We note that this is likely due to
the lower transport rate of platelets to the adhesive surface.
Phase contrast microscopy (Fig. 3c) showed that in addition to
single adherent platelets also small aggregates (5–20 platelets)
attached to the fibrin surface. Aggregation in the thrombin-
activated platelet suspension was however, not observed. Cyto-
solic calcium concentrations were measured in adherent plate-
lets 10 min after the start of the perfusion. The [Ca2þ]i of these
thrombin-activated platelets was 0.2 0.1mmol L1 (mean 
SD; n ¼ 5) and thus higher than the basal level of 50 nmol L1
of platelets that adhered to VWF in the absence of thrombin
under high-shear conditions. Yet, after low-shear perfusion
only a few platelets (11 8%; mean  SD, n ¼ 30) bound
annexin V.
To investigate whether at low shear rate VWF was also
involved in fibrin adhesion of thrombin-activated platelets,
we investigated the effect of a blocking polyclonal rabbit
antihuman VWF antibody (10 mg mL1). With this antibody
Fig. 3. Effect of thrombin on platelet adhesion to fibrin under low shear stress. (a) Calcein-loaded washed platelets (3.9 108 cells mL1) resuspended in
Hepes buffer (see Fig. 1) were perfused in the absence (&) and presence of 100 nmol L1 thrombin (*) at a wall shear rate of 50 s1 over a fibrin layer that was
treated with human VWF (10mg mL1) and PPACK (50mmol L1) as described. Fluorescence images were captured and analyzed off-line for the surface
coverage with platelets. (b) Following a 5-min rinse with Hepes to remove non-bound platelets, fluorescence images were captured from 5 different
microscopic fields and off-line analyzed for surface coverage with stationary platelets. VWF and PPACK treated fibrin were perfused with: non-treated,
washed platelets (control) and thrombin-activated platelets (thrombin). In addition, thrombin-activated platelets were perfused over fibrin that was
incubated with 10mg mL1 polyclonal antihuman VWF antibody (Thrombin þ a-VWF). (c) Phase contrast image of the fibrin layer after 10 min perfusion
with thrombin-activated platelets and subsequent rinse with Hepes.
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present, the area coverage with adherent platelets was 27 9%
(mean  SD; n ¼ 15), which is not significantly different
(P¼ 0.13) from that observed in the control experiment, i.e.
12 7% (mean  SD; n ¼ 15). Accordingly, at low shear rate,
VWF does not appear to play a significant role in the adhesion
of thrombin-activated platelets to fibrin.
Botrocetin and exposure of PS at fibrin-adherent platelet
To achieve VWF-mediated platelet adhesion at a low shear rate
(50 s1), washed platelets were passed over a VWF-fibrin layer
that was preincubated with botrocetin (5 U mL1). Ten minutes
after the start of the flow 11 4% (mean  SD; n ¼ 10) of the
area was covered with platelets. The cytosolic calcium con-
centration, amounting to 70 nmol L1, of these platelets was not
substantially increased above the basal level of 50 nmol L1.
The percentage of adherent platelets that bound annexin V also
remained low, namely 1.3 2.3% (mean  SD; n ¼ 20).
However, when a thrombin solution (100 nmol L1) was passed
over the fibrin/botrocetin-adherent platelets, [Ca2þ]i immedi-
ately increased to 0.7mmol L1 (Fig. 4a), while 57 23%
(mean  SD; n ¼ 20) of the adherent platelets bound annexin
V, as measured 10 min after the start of the perfusion with a
thrombin-annexin V solution (Fig. 4b). That under these con-
ditions platelet adhesion was mediated by VWF appeared from
the observation that preincubation of the botrocetin-contained
coverslip with anti-VWF antibody completely abolished botro-
cetin-induced platelet adhesion.
In conclusion, this study that utilized a plasma-free flow
system clearly demonstrated that shear-induced platelet adhe-
sion to fibrin is not accompanied with substantially elevated
[Ca2þ]i, nor associated with exposure of annexin V binding sites
on the platelet surface. Thrombin, however, induced a transient
increase in [Ca2þ]i of the adherent platelets, which at high shear
but not at low shear was followed by the exposure of annexin V
binding sites. This indicates that VWF-mediated adhesion of
platelets to fibrin is a prerequisite for thrombin to expose PS on
the outer leaflet of the platelet plasma membrane. It is apparent
that sufficiently high [Ca2þ]i levels for maximal PS exposure in
fibrin-adherent platelets are obtained by a synergistic signal
mechanism in which both VWF and thrombin need to interact
with their receptors on fibrin-adherent platelets.
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